|
|
|
Taiwan-Silicon Valley
2004 Biomedical Conference
Biomedical Opportunities and Business Alliance
Between Asia and the United States
Sponsors: CBA,
COA, DCB, Monte Jade, NATEA, SRI International, STAG, TAITA, TAITRA, TBIO, TECO in
SF, ITRI
An exciting upcoming 2004 Taiwan-Silicon Valley Biomedical Conference
will be held on June 5, 2004 at Marriott Hotel in Santa Clara, California.
We expect over 500 attendees representing academia, government, venture
capitals and the biomedical industries from both U.S. and Taiwan to converge
at the event. This event provides you great opportunity to learn more about
the biomedical industry as well as a chance to network with the biomedical
community.
The focus of this conference is to address issues concerning potential Taiwan-US
biomedical industry alliances and explore what it means to the progress
of biomedical development. We have invited eleven distinguished speakers,
each will present his/her views on how to construct successful policies,
strategic plans, and business and collaboration models in the booming biomedical
industry. |
| Feature
Presentation Overview: |
• A Multi-disciplinary Approach to Building
a Successful Medical Device Industry
by
Dr. Paul G. Yock, Professor of Medical and Mechanical Engineering, Stanford University
|
|
• Biotech-The Rising Star After The High Tech Bubble
by Dr. Bryan E. Roberts, General Partner, Venrock Associates |
• Leapfrogging Strategy for of Biotech Industry in Asia
by Dr. Frank Kung, Managing General Partner, BioAsia |
• The Present and
Future of Taiwan’s Biotech Industry Development: |
• Leveraging Taiwan’s Advantages for Global Biotech Competitiveness
by Dr.Johnsee Lee, President, ITRI, Taiwan |
• Biotech Partnering
Strategies-from Taiwan to the World
by Dr. Jui-Lien Huang, President, DCB, Taiwan |
• Taiwan-Your Partner
for Globalization and Localization
by Mr. David Liu, VP, TAITRA, Taiwan |
• Bridging the 'Valley of Death': New Approaches and Models for
Pharmaceutical Drug Development in the US and Asia
by Dr. Glenn Rice, VP, Biosciences Division, SRI International |
• Diagnostics for
the Real World
by Dr. Helen H.Lee , President & CEO, Diagnostics for the Real World, Ltd. |
• Accelerating Development
of Taiwan Pharmaceutical Industry
by Dr. Ming-Chu Hsu, President & CEO, TaiGen Biotechnology Company Ltd. |
• From Product Concept
To The Market Leader
by Dr. Karen Talmadge, Executive VP& CSO, Kyphon Inc. |
• Panel Discussion: Critical Issues of Cross-Pacific Business
Alliance and Technology Collaboration:
• Moderator: Dr. Yue-Teh Jang, General Partner, The Vertical Group.
• Panelist: Dr. Johnsee Lee, President, Taiwan Bio Industry Organization,
• Dr, Kee Lung Hong, Founder and CTO, Hermes Biotech
• Dr. Por Lai, President, President Life, Taiwan
• David Saul, J.D., Partner, Wilson Sonsini Goodrich & Rosati
• Dr. Tony Chou, M.D., General Manager, Abbott Laboratories
|
|
|
| Registration |
Registration
Fees
(Pre-reg online): |
Before 6/5/2004* (pre-reg) |
On 6/5/2004 (On-site) |
Students |
$15 |
$20 |
All |
$30 |
$40 |
All prices include lunch.
*Payment check must be post-marked by 6/4/2004. |
|
|
